Panhematin for Prevention of Acute Attacks of Porphyria
Condition(s):Acute Intermittent Porphyria; Hereditary Coproporphyria; Variegate PorphyriaLast Updated:February 8, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Acute Intermittent Porphyria; Hereditary Coproporphyria; Variegate PorphyriaLast Updated:February 8, 2023Recruiting
Condition(s):Myelodysplastic SyndromeLast Updated:October 24, 2014Terminated
Condition(s):Acute PorphyriasLast Updated:March 31, 2023Completed
Condition(s):Post-ERCP Acute PancreatitisLast Updated:July 7, 2021Completed
Condition(s):Gastroparesis; Diabetes MellitusLast Updated:February 4, 2016Completed
Condition(s):Healthy VolunteersLast Updated:April 17, 2009Completed
Condition(s):Acute Intermittent Porphyria; Hereditary Coproporphyria; Variegate PorphyriaLast Updated:March 31, 2023Active, not recruiting
Condition(s):Iron-deficiency; Menorrhagia; AnemiaLast Updated:November 22, 2023Completed
Condition(s):Uterine Leiomyoma; Uterine FibroidsLast Updated:April 26, 2022Completed
Condition(s):Graft Failure; Ischemia-reperfusion InjuryLast Updated:May 27, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.